Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099411 · ClinicalTrials.gov registry record
Heart Muscle Viability and Remodeling in Individuals Post-Heart Attack
A clinical trial, sponsored by Tufts Medical Center.
- Completed
- Registry status
- 124
- Enrollment target
NCT00099411 is a clinical trial that has completed, run by Tufts Medical Center. The registered enrollment target is 124 participants.
The verdict
NCT00099411 has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of heart muscle viability on left ventricular (LV) remodeling after a heart attack; to explore the relationships between retained viability of the area of tissue death (infarct zone), LV remodeling, response to the Occluded Artery Trial (OAT) intervention, and response to late percutaneous coronary intervention of the infarct related artery (IRA).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00099411
The ClinicalTrials.gov registry entry for NCT00099411 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00099411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00099411 about?
NCT00099411 is a clinical study titled "Heart Muscle Viability and Remodeling in Individuals Post-Heart Attack". The purpose of this study is to assess the effect of heart muscle viability on left ventricular (LV) remodeling after a heart attack; to explore the relationships between retained viability of the area of tissue death (infarct zone), LV remodeling, response to the Occluded Artery Trial (OAT) interve...
What is the current status of trial NCT00099411?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2004-01. Estimated completion is 2007-06-30.
Who is sponsoring clinical trial NCT00099411?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.